These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 22160002)
1. Adenosine A2A receptor contributes to the anti-inflammatory effect of the fixed herbal combination STW 5 (Iberogast®) in rat small intestinal preparations. Michael S; Abdel-Aziz H; Weiser D; Müller CE; Kelber O; Nieber K Naunyn Schmiedebergs Arch Pharmacol; 2012 Apr; 385(4):411-21. PubMed ID: 22160002 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of inflammation-induced alterations in rat small intestine by the herbal preparations STW 5 and STW 6. Michael S; Kelber O; Hauschildt S; Spanel-Borowski K; Nieber K Phytomedicine; 2009 Mar; 16(2-3):161-71. PubMed ID: 19196500 [TBL] [Abstract][Full Text] [Related]
3. Antispasmodic effects of myrrh due to calcium antagonistic effects in inflamed rat small intestinal preparations. Vissiennon C; Goos KH; Goos O; Nieber K Planta Med; 2015 Jan; 81(2):116-22. PubMed ID: 25590370 [TBL] [Abstract][Full Text] [Related]
4. Adenosine A(2A) agonist and A(2B) antagonist mediate an inhibition of inflammation-induced contractile disturbance of a rat gastrointestinal preparation. Michael S; Warstat C; Michel F; Yan L; Müller CE; Nieber K Purinergic Signal; 2010 Mar; 6(1):117-24. PubMed ID: 20020217 [TBL] [Abstract][Full Text] [Related]
5. Spasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth muscle. Ammon HP; Kelber O; Okpanyi SN Phytomedicine; 2006; 13 Suppl 5():67-74. PubMed ID: 16978852 [TBL] [Abstract][Full Text] [Related]
6. Binding of STW 5 (Iberogast) and its components to intestinal 5-HT, muscarinic M3, and opioid receptors. Simmen U; Kelber O; Okpanyi SN; Jaeggi R; Bueter B; Weiser D Phytomedicine; 2006; 13 Suppl 5():51-5. PubMed ID: 16973340 [TBL] [Abstract][Full Text] [Related]
7. [STW 5/Iberogast: multi-target-action for treatment of functional dyspepsia and irritable bowel syndrome]. Allescher HD; Wagner H Wien Med Wochenschr; 2007; 157(13-14):301-7. PubMed ID: 17704976 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of the anti-proliferative and anti-inflammatory effects of the herbal fixed combination STW 5 (Iberogast®) on colon adenocarcinoma (HT29) cells in vitro. Bonaterra GA; Kelber O; Weiser D; Kinscherf R Phytomedicine; 2013 Jun; 20(8-9):691-8. PubMed ID: 23535188 [TBL] [Abstract][Full Text] [Related]
9. STW 5 (Iberogast) reduces afferent sensitivity in the rat small intestine. Müller MH; Liu CY; Glatzle J; Weiser D; Kelber O; Enck P; Grundy D; Kreis ME Phytomedicine; 2006; 13 Suppl 5():100-6. PubMed ID: 16713220 [TBL] [Abstract][Full Text] [Related]
10. The multi-herbal drug STW 5 (Iberogast) has prosecretory action in the human intestine. Krueger D; Gruber L; Buhner S; Zeller F; Langer R; Seidl S; Michel K; Schemann M Neurogastroenterol Motil; 2009 Nov; 21(11):1203-e110. PubMed ID: 19210628 [TBL] [Abstract][Full Text] [Related]
11. STW 5 (Iberogast®)--a safe and effective standard in the treatment of functional gastrointestinal disorders. Ottillinger B; Storr M; Malfertheiner P; Allescher HD Wien Med Wochenschr; 2013 Feb; 163(3-4):65-72. PubMed ID: 23263639 [TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory and tight junction protective activity of the herbal preparation STW 5-II on mouse intestinal organoids. Elbadawi M; Ammar RM; Aziz-Kalbhenn H; Rabini S; Klauck SM; Dawood M; Saeed MEM; Kampf CJ; Efferth T Phytomedicine; 2021 Jul; 88():153589. PubMed ID: 34111617 [TBL] [Abstract][Full Text] [Related]
13. Radical scavenging and anti-inflammatory properties of STW 5 (Iberogast) and its components. Schempp H; Weiser D; Kelber O; Elstner EF Phytomedicine; 2006; 13 Suppl 5():36-44. PubMed ID: 16777393 [TBL] [Abstract][Full Text] [Related]
14. Intranasal administration of NECA can induce both anti-inflammatory and pro-inflammatory effects in BALB/c mice: evidence for A 2A receptor sub-type mediation of NECA-induced anti-inflammatory effects. El-Hashim AZ; Abduo HT; Rachid OM; Luqmani YA; Al Ayadhy BY; Alkhaledi GM Pulm Pharmacol Ther; 2009 Jun; 22(3):243-52. PubMed ID: 19146972 [TBL] [Abstract][Full Text] [Related]
15. Mucosal function in rat jejunum and ileum is altered by induction of colitis. Amit-Romach E; Reifen R; Uni Z Int J Mol Med; 2006 Oct; 18(4):721-7. PubMed ID: 16964428 [TBL] [Abstract][Full Text] [Related]
16. The herbal preparation STW 5 (Iberogast) desensitizes intestinal afferents in the rat small intestine. Liu CY; Müller MH; Glatzle J; Weiser D; Kelber O; Enck P; Grundy D; Kreis ME Neurogastroenterol Motil; 2004 Dec; 16(6):759-64. PubMed ID: 15601426 [TBL] [Abstract][Full Text] [Related]
17. Small-bowel obstruction and the effects of lidocaine, atropine and hexamethonium on inflammation and fluid losses. Nellgård P; Jönsson A; Bojö L; Tarnow P; Cassuto J Acta Anaesthesiol Scand; 1996 Mar; 40(3):287-92. PubMed ID: 8721458 [TBL] [Abstract][Full Text] [Related]
18. Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis. Antonioli L; Fornai M; Colucci R; Awwad O; Ghisu N; Tuccori M; Del Tacca M; Blandizzi C Eur J Pharmacol; 2011 Jan; 650(2-3):639-49. PubMed ID: 21034735 [TBL] [Abstract][Full Text] [Related]
19. A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis. Antonioli L; Fornai M; Colucci R; Ghisu N; Blandizzi C; Del Tacca M Inflamm Bowel Dis; 2006 Feb; 12(2):117-22. PubMed ID: 16432376 [TBL] [Abstract][Full Text] [Related]